Solara Active Pharma Sciences Ltd. | Small-cap | Healthcare
₹617.70
-0.50%
| Solara Active Pharma Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 12.8B
Gross Profit 6.6B 51.21%
Operating Income 1.1B 8.34%
Net Income 5.4M 0.04%
EPS (Diluted) ₹0.14

Balance Sheet Metrics

Total Assets 22.3B
Total Liabilities 11.3B
Shareholders Equity 11.0B
Debt to Equity 1.03

Cash Flow Metrics

Operating Cash Flow 1.7B
Free Cash Flow 1.7B

Revenue & Profitability Trend

Solara Active Pharma Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 12.8B 12.4B 13.8B 12.3B 15.8B
Cost of Goods Sold 6.3B 8.4B 8.1B 6.8B 7.5B
Gross Profit 6.6B 4.0B 5.7B 5.5B 8.2B
Operating Expenses 2.4B 3.0B 2.6B 2.7B 2.4B
Operating Income 1.1B -2.0B 331.6M -298.3M 2.8B
Pre-tax Income 5.4M -4.9B -448.2M -911.0M 2.2B
Income Tax 0 785.4M -225.7M -328.1M 1.5M
Net Income 5.4M -5.7B -222.5M -582.9M 2.2B
EPS (Diluted) ₹0.14 -₹145.27 -₹5.68 -₹14.91 ₹59.47

Income Statement Trend

Solara Active Pharma Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 7.3B 8.0B 11.9B 12.4B 10.6B
Non-Current Assets 15.0B 15.5B 17.1B 17.1B 15.6B
Total Assets 22.3B 23.5B 29.0B 29.4B 26.1B
Liabilities
Current Liabilities 9.4B 12.4B 11.0B 10.6B 7.9B
Non-Current Liabilities 1.9B 1.7B 3.0B 3.5B 2.3B
Total Liabilities 11.3B 14.1B 14.0B 14.2B 10.2B
Equity
Total Shareholders Equity 11.0B 9.4B 15.0B 15.3B 15.9B

Balance Sheet Composition

Solara Active Pharma Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 5.4M -4.9B -448.2M -911.0M 2.2B
Operating Cash Flow 1.7B -1.4B -165.4M -3.3B -152.3M
Investing Activities
Capital Expenditures 3.8M 10.4M 13.0M 1.3M 29.7M
Investing Cash Flow 23.6M 20.1M 51.7M 57.2M 85.7M
Financing Activities
Dividends Paid - - - -107.8M -197.3M
Financing Cash Flow -623.6M -21.4M -228.8M 4.1B 1.8B
Free Cash Flow 1.7B 678.1M 449.4M -4.5B -190.2M

Cash Flow Trend

Solara Active Pharma Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 3,971.25
Forward P/E 19.55
Price to Book 2.34
Price to Sales 2.22
PEG Ratio 19.55

Profitability Ratios

Profit Margin 0.04%
Operating Margin 7.72%
Return on Equity 0.05%
Return on Assets 2.92%

Financial Health

Current Ratio 0.77
Debt to Equity 72.58
Beta 0.99

Per Share Data

EPS (TTM) ₹0.16
Book Value per Share ₹271.86
Revenue per Share ₹332.83

Financial data is updated regularly. All figures are in the company's reporting currency.